Dr. Jean-Simon Diallo (Ph.D) is a Scientist with broad expertise in biochemistry, molecular biology, cancer therapeutics, and viral immunology. He is an internationally recognized expert in oncolytic virotherapy and was seminal in the discovery of the Viral Sensitizer technology as well as in its development for virus manufacturing and cancer therapy applications in combination with oncolytic viruses. Dr. Diallo is a Senior Scientist at the Ottawa Hospital and an Assistant Professor of Biochemistry, Microbiology and Immunology within the Faculty of Medicine at the University of Ottawa. He is co-founder and CEO of Virica biotech.

• 

  Chief Executive Officer (CEO) in Virica Biotech​

  UNLOCK THE POTENTIAL OF YOUR THERAPEUTIC

• 

  Co-Founder in Virica Biotech​

  UNLOCK THE POTENTIAL OF YOUR THERAPEUTIC